Skip to main content
$1.18 $0.13 (12.4%)

04:00 PM EDT on 09/28/22

Clovis Oncology Inc (NASDAQ:CLVS)

CAPS Rating: 1 out of 5

Current Price $1.18 Mkt Cap $151.7M
Open $1.07 P/E Ratio 0.00
Prev. Close $1.18 Div. (Yield) $0.00 (0.0%)
Daily Range $1.06 - $1.22 Volume 3,004,974
52-Wk Range $0.58 - $4.76 Avg. Daily Vol. 3,851,979

Caps

How do you think NASDAQ:CLVS will perform against the market?

Add Stock to CAPS Watchlist

All Players

54 Outperform
17 Underperform
 

All-Star Players

10 Outperform
6 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CLVS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.74)
Submitted February 16, 2016

Clovis isn't exactly flying under the radar ahead of the rociletinib Ad Comm on April 12. There's lots of commentary on the drug's prospects for approval, most of it negative. Of course, the shocking aspect of the whole situation was the blase way in… More

TerryHogan (99.73)
Submitted October 10, 2018

The financials on this one are fishier than a murder mystery dinner theater in Newfoundland. You can expect SG&A to go up in line with revenue a bit, but why does R&D increase with every revenue increase to wipe out all profits? I'm not saying… More

Recent Community Commentary

Read the most recent pitches from players about CLVS.

Recs

0
Member Avatar TMFjimhalley (< 20) Submitted: 5/12/2022 1:07:26 PM : Outperform Start Price: $1.74 NASDAQ:CLVS Score: -32.15

It has a blockbuster drug, Rubraca, that has wide potential in oncology.

Recs

0
Member Avatar Capitalism (69.54) Submitted: 2/26/2018 1:20:40 PM : Outperform Start Price: $55.12 NASDAQ:CLVS Score: -131.53

Richard Marzouka (SA) pick.

Recs

0
Member Avatar LifeScientist (44.14) Submitted: 2/17/2016 3:19:38 PM : Outperform Start Price: $19.78 NASDAQ:CLVS Score: -186.38

technical near term bottom and nice upside two day trend; no insider selling of late since the drop last Nov. ( however no buying reported for 12 mos. ) top fools ZZlangerhaus and Seth15701 like it and former had a reasonable analysis .... Note, due to announce on Feb 25, so have to decide whether to hold it through earnings, but street's got a good negative expect of cash burn. Credit Suisse has picked it up with an analysis and an outperform since the Nov price drop.

Leaderboard

Find the members with the highest scoring picks in CLVS.

Score Leader

anchak

anchak (99.86) Score: +387.02

The Score Leader is the player with the highest score across all their picks in CLVS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
KidJones 30.02 12/3/2012 Underperform 5Y $15.59 -92.43% +161.62% +254.05 0 Comment
MFBurritoSquat 50.38 11/30/2012 Underperform 3M $15.81 -92.54% +160.85% +253.39 0 Comment
IBDContrarian 67.03 4/8/2013 Underperform 5Y $29.05 -95.94% +138.62% +234.56 1 Comment
kurzzz 91.02 6/25/2013 Underperform 5Y $65.00 -98.18% +133.79% +231.97 0 Comment
ExpressRocks 83.80 6/25/2013 Underperform 5Y $63.88 -98.15% +133.72% +231.87 0 Comment
bluebare 28.51 6/14/2013 Underperform 5Y $69.38 -98.30% +127.32% +225.62 0 Comment
kevian 65.13 6/3/2013 Underperform 1Y $71.74 -98.36% +125.74% +224.10 0 Comment
goldminingXpert 27.57 5/13/2013 Underperform NS $37.75 -96.87% +126.27% +223.15 0 Comment
navychop2 45.57 6/12/2014 Underperform 1Y $43.34 -97.28% +90.35% +187.62 2 Comments
GuruExp 93.31 10/7/2014 Underperform 5Y $47.02 -97.49% +89.73% +187.22 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CLVS.